FR2452930A1 - Nouveau complexe antitumoral-antibacterien et son procede de production - Google Patents

Nouveau complexe antitumoral-antibacterien et son procede de production

Info

Publication number
FR2452930A1
FR2452930A1 FR8007145A FR8007145A FR2452930A1 FR 2452930 A1 FR2452930 A1 FR 2452930A1 FR 8007145 A FR8007145 A FR 8007145A FR 8007145 A FR8007145 A FR 8007145A FR 2452930 A1 FR2452930 A1 FR 2452930A1
Authority
FR
France
Prior art keywords
complex
producing
bbm
same
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8007145A
Other languages
English (en)
French (fr)
Other versions
FR2452930B1 (sv
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2452930A1 publication Critical patent/FR2452930A1/fr
Application granted granted Critical
Publication of FR2452930B1 publication Critical patent/FR2452930B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
FR8007145A 1979-04-02 1980-03-31 Nouveau complexe antitumoral-antibacterien et son procede de production Granted FR2452930A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648879A 1979-04-02 1979-04-02

Publications (2)

Publication Number Publication Date
FR2452930A1 true FR2452930A1 (fr) 1980-10-31
FR2452930B1 FR2452930B1 (sv) 1983-12-30

Family

ID=21832125

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8007145A Granted FR2452930A1 (fr) 1979-04-02 1980-03-31 Nouveau complexe antitumoral-antibacterien et son procede de production

Country Status (24)

Country Link
JP (3) JPS55162752A (sv)
AR (1) AR223372A1 (sv)
AT (1) AT371144B (sv)
AU (1) AU533672B2 (sv)
BE (1) BE882574A (sv)
CH (1) CH647247A5 (sv)
DE (1) DE3012565A1 (sv)
DK (1) DK153501C (sv)
ES (1) ES490209A0 (sv)
FI (1) FI67403C (sv)
FR (1) FR2452930A1 (sv)
GB (1) GB2050384B (sv)
GR (1) GR66663B (sv)
HU (1) HU184256B (sv)
IE (1) IE49191B1 (sv)
IL (1) IL59746A (sv)
LU (1) LU82318A1 (sv)
NL (1) NL8001868A (sv)
NO (1) NO155780C (sv)
PH (1) PH16970A (sv)
SE (1) SE441930B (sv)
SU (1) SU999981A3 (sv)
YU (1) YU41700B (sv)
ZA (1) ZA801856B (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540116A1 (fr) * 1983-01-31 1984-08-03 Bristol Myers Co Nouvel antibiotique et antitumoral, la luzopeptine e2, son procede de preparation, et les compositions pharmaceutiques utilisant cet antibiotique

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416874A (en) 1982-03-05 1983-11-22 Bristol-Myers Company Injectable compositions of BBM-928A
ATE31623T1 (de) * 1983-09-14 1988-01-15 Bristol Myers Co Injizierbare zusammensetzungen von bbm-928a.
US6749993B2 (en) 2002-02-06 2004-06-15 Konica Corporation Planographic printing precursor and printing method employing the same
JP2003300382A (ja) 2002-04-08 2003-10-21 Konica Minolta Holdings Inc 熱転写中間転写媒体を用いた画像形成方法
JP2004188848A (ja) 2002-12-12 2004-07-08 Konica Minolta Holdings Inc 印刷版材料
JP2004322511A (ja) 2003-04-25 2004-11-18 Konica Minolta Medical & Graphic Inc 印刷方法
JP2006056184A (ja) 2004-08-23 2006-03-02 Konica Minolta Medical & Graphic Inc 印刷版材料および印刷版
EP1944174A1 (en) 2005-11-01 2008-07-16 Konica Minolta Medical & Graphic, Inc. Lithographic printing plate material, lithographic printing plate, method for preparing lithographic printing plate, and method for printing by lithographic printing plate
JP4878612B2 (ja) * 2008-07-16 2012-02-15 スタンレー電気株式会社 車両用信号灯具
US9052217B2 (en) 2012-11-09 2015-06-09 Honeywell International Inc. Variable scale sensor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540116A1 (fr) * 1983-01-31 1984-08-03 Bristol Myers Co Nouvel antibiotique et antitumoral, la luzopeptine e2, son procede de preparation, et les compositions pharmaceutiques utilisant cet antibiotique

Also Published As

Publication number Publication date
JPS63139191A (ja) 1988-06-10
DE3012565C2 (sv) 1990-11-08
JPS6365679B2 (sv) 1988-12-16
IE49191B1 (en) 1985-08-21
ES8104411A1 (es) 1981-04-16
LU82318A1 (fr) 1980-12-16
AT371144B (de) 1983-06-10
YU41700B (en) 1987-12-31
JPH0341475B2 (sv) 1991-06-24
FR2452930B1 (sv) 1983-12-30
NO155780B (no) 1987-02-16
NL8001868A (nl) 1980-10-06
ZA801856B (en) 1981-04-29
AR223372A1 (es) 1981-08-14
AU533672B2 (en) 1983-12-08
AU5700280A (en) 1980-10-09
YU81280A (en) 1983-09-30
PH16970A (en) 1984-04-27
GB2050384A (en) 1981-01-07
NO155780C (no) 1987-05-27
JPS63139192A (ja) 1988-06-10
ATA180380A (de) 1982-10-15
GR66663B (sv) 1981-04-07
DE3012565A1 (de) 1980-10-23
GB2050384B (en) 1983-04-07
CH647247A5 (fr) 1985-01-15
DK153501C (da) 1988-11-28
SE8002521L (sv) 1980-10-03
IL59746A (en) 1983-02-23
ES490209A0 (es) 1981-04-16
IL59746A0 (en) 1980-06-30
DK138780A (da) 1980-10-03
SU999981A3 (ru) 1983-02-23
IE800598L (en) 1980-10-02
JPH0341157B2 (sv) 1991-06-21
HU184256B (en) 1984-07-30
DK153501B (da) 1988-07-18
FI67403C (fi) 1985-03-11
NO800967L (no) 1980-10-03
FI800973A (fi) 1980-10-03
SE441930B (sv) 1985-11-18
FI67403B (fi) 1984-11-30
JPS55162752A (en) 1980-12-18
BE882574A (fr) 1980-10-01

Similar Documents

Publication Publication Date Title
Friedman et al. Nutritional and medicinal aspects of D-amino acids
Baxter et al. Stimulation of 25-hydroxyvitamin D3-1alpha-hydroxylase by phosphate depletion.
FR2452930A1 (fr) Nouveau complexe antitumoral-antibacterien et son procede de production
ATE84414T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus.
Feung et al. Metabolism of indole-3-acetic acid: IV. Biological properties of amino acid conjugates
DE69333575D1 (de) Quinone-derivate zur verbesserung der zellulare bioenergie
RU2002123877A (ru) Кахалалидные соединения
Penner et al. Proteolytic enzyme control in squash cotyledons
Emanuelsson et al. Inhibition of putrescine synthesis blocks development of the polychete Ophryotrocha labronica at gastrulation.
CN106860485A (zh) 治疗失智症的活性物质、含其的组合物及其制备方法
Prange Jr et al. Influence of age on monoamine oxidase and catechol-O-methyltransferase in rat tissues
Anker Auxin‐synthesis inhibition by sugars, notably by galactose
BE1001527A6 (fr) Preparation aqueuse stabilisee d'acide folique.
Boor et al. In vivo metabolism of the cardiovascular toxin, allylamine
FR2434162A1 (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
RU2093154C1 (ru) Фармкомпозиция для профилактики и лечения заболеваний, связанных с нарушением обмена веществ
DK0488928T3 (da) Pharmaceutiske formuleringer, der indeholder en blanding af højere, primære, alifatiske alkoholer, til behandling af hyperc
DE4326698C2 (de) Verwendung einer Kombination aus Folsäure, Vitamin B¶6¶ und Vitamin B¶1¶¶2¶ zur Prophylaxe und Therapie von Arteriosklerose
DE4326675C2 (de) Verwendung einer Kombination aus Folsäure, Vitamin B¶6¶ und Vitamin B¶1¶¶2¶ zur Vorbeugung von Nervendegenerationserkrankungen und Altersdementia
RU94035663A (ru) Аналоги витамина d3
Bond The action of fumigants on insects: III. The fate of hydrogen cyanide in Sitophilus granarius (L.)
ATE7202T1 (de) Nichtadsorbierbare, mukolytische verbindungen, verfahren zu ihrer herstellung und therapeutische zusammensetzungen, die diese verbindungen als wirkstoff enthalten.
CA2322055A1 (fr) Nouvelle famille de canaux potassium de mammiferes mecanosensibles et actives par les acides gras polyinsatures et leur utilisation notamment pour le criblage de drogues
MX9706283A (es) Nuevos antibioticos de polieno, 3874 hi a h6, procedimientos para su preparacion y empleo.
DE102006058183A1 (de) Verwendung von Substanzen, die den zellulären Glutathion-Gehalt absenken, zur Herstellung eines Arzneimittels zur Behandlung von T-Zell vermittelten Autoimmunkrankheiten

Legal Events

Date Code Title Description
ST Notification of lapse